Literature DB >> 20610716

Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway.

Spyridon Stavrou1, Zongdi Feng, Stanley M Lemon, Raymond P Roos.   

Abstract

The DA strain of Theiler's murine encephalomyelitis virus (TMEV), a member of the Cardiovirus genus of the family Picornaviridae, causes persistent infection in susceptible mice, associated with restricted expression of viral proteins, and induces a demyelinating disease of the central nervous system. DA-induced demyelinating disease serves as a model of human multiple sclerosis because of similarities in pathology and because host immune responses contribute to pathogenesis in both disorders. In contrast, the GDVII strain of TMEV causes acute lethal encephalitis with no virus persistence. Cardiovirus L is a multifunctional protein that blocks beta interferon (IFN-beta) gene transcription. We show that both DA L and GDVII L disrupt IFN-beta gene transcription induction by IFN regulatory factor 3 (IRF-3) but do so at different points in the signaling pathway. DA L blocks IFN-beta gene transcription downstream of mitochondrial antiviral signaling protein (MAVS) but upstream of IRF-3 activation, while GDVII L acts downstream of IRF-3 activation. Both DA L and GDVII L block IFN-beta gene transcription in infected mice; however, IFN-beta mRNA is expressed at low levels in the central nervous systems of mice persistently infected with DA. The particular level of IFN-beta mRNA expression set by DA L as well as other factors in the IRF-3 pathway may play a role in virus persistence, inflammation, and the restricted expression of viral proteins during the late stage of demyelinating disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610716      PMCID: PMC2937600          DOI: 10.1128/JVI.00603-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Interferons alpha and beta as immune regulators--a new look.

Authors:  C A Biron
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

2.  The mengovirus leader protein blocks interferon-alpha/beta gene transcription and inhibits activation of interferon regulatory factor 3.

Authors:  Stanleyson V Hato; Celine Ricour; Barbara M Schulte; Kjerstin H W Lanke; Mike de Bruijni; Jan Zoll; Willem J G Melchers; Thomas Michiels; Frank J M van Kuppeveld
Journal:  Cell Microbiol       Date:  2007-12       Impact factor: 3.715

3.  Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon.

Authors:  J Chinsangaram; M E Piccone; M J Grubman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes.

Authors:  Nathalie Grandvaux; Marc J Servant; Benjamin tenOever; Ganes C Sen; Siddarth Balachandran; Glen N Barber; Rongtuan Lin; John Hiscott
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production.

Authors:  V van Pesch; O van Eyll; T Michiels
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: roles of CD4+ and CD8+ T cells and viral persistence.

Authors:  R M Ransohoff; T Wei; K D Pavelko; J-C Lee; P D Murray; M Rodriguez
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Inhibition of mRNA export and dimerization of interferon regulatory factor 3 by Theiler's virus leader protein.

Authors:  Céline Ricour; Sophie Delhaye; Stanleyson V Hato; Tamara D Olenyik; Bénédicte Michel; Frank J M van Kuppeveld; Kurt E Gustin; Thomas Michiels
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

8.  Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex.

Authors:  Atsushi Matsuzawa; Ping-Hui Tseng; Sivakumar Vallabhapurapu; Jun-Li Luo; Weizhou Zhang; Haopeng Wang; Dario A A Vignali; Ewen Gallagher; Michael Karin
Journal:  Science       Date:  2008-07-17       Impact factor: 47.728

9.  Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients.

Authors:  Lisa G M van Baarsen; Saskia Vosslamber; Marianne Tijssen; Josefien M C Baggen; Laura F van der Voort; Joep Killestein; Tineke C T M van der Pouw Kraan; Chris H Polman; Cornelis L Verweij
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

10.  Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3.TANK.TBK1/IKKepsilon complex.

Authors:  Kam-Leung Siu; Kin-Hang Kok; Ming-Him James Ng; Vincent K M Poon; Kwok-Yung Yuen; Bo-Jian Zheng; Dong-Yan Jin
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

View more
  13 in total

1.  The L-coding region of the DA strain of Theiler's murine encephalomyelitis virus causes dysfunction and death of myelin-synthesizing cells.

Authors:  G D Ghadge; R Wollmann; G Baida; M Traka; R P Roos
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 2.  Animal Models of Zika Virus.

Authors:  Michael P Bradley; Claude M Nagamine
Journal:  Comp Med       Date:  2017-06-01       Impact factor: 0.982

3.  Apoptotic and antiapoptotic activity of L protein of Theiler's murine encephalomyelitis virus.

Authors:  Spyridon Stavrou; Ghanashyam Ghadge; Raymond P Roos
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

4.  Identification of a novel neuropathogenic Theiler's murine encephalomyelitis virus.

Authors:  Matthew R Buckwalter; Phan Thi Nga; Meriadeg Ar Gouilh; Laurence Fiette; Jean-Francois Bureau; Melissa E Laird; Julian Buchrieser; Simona Ozden; Justine Cheval; Marc Eloit; Jean-Claude Manuguerra; Antoine Gessain; Paul T Brey; Arnaud Fontanet; Matthew L Albert
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

Review 5.  Viruses and Multiple Sclerosis: From Mechanisms and Pathways to Translational Research Opportunities.

Authors:  Alexios-Fotios A Mentis; Efthimios Dardiotis; Nikolaos Grigoriadis; Efthimia Petinaki; Georgios M Hadjigeorgiou
Journal:  Mol Neurobiol       Date:  2017-04-28       Impact factor: 5.590

6.  The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.

Authors:  Francesca Gilli; Libin Li; Andrew R Pachner
Journal:  J Neurovirol       Date:  2015-08-11       Impact factor: 2.643

7.  Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection.

Authors:  Jingshan Zhang; Howard L Lipton; Alan S Perelson; Harel Dahari
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

8.  Mutation of the Theiler's virus leader protein zinc-finger domain impairs apoptotic activity in murine macrophages.

Authors:  Kyung-No Son; Zhiguo Liang; Howard L Lipton
Journal:  Virus Res       Date:  2013-09-10       Impact factor: 3.303

9.  The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.

Authors:  Kevin D Pavelko; Michael P Bell; Lavakumar Karyampudi; Michael J Hansen; Kathleen S Allen; Keith L Knutson; Larry R Pease
Journal:  Mol Ther       Date:  2013-04-09       Impact factor: 11.454

10.  Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.

Authors:  Lin Li; Reiner Ulrich; Wolfgang Baumgärtner; Ingo Gerhauser
Journal:  J Neuroinflammation       Date:  2015-12-24       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.